Sign in Subscribe
Medical equipment industry

Cortech and BioStar Terminate Merger Agreement

Strategic Insights

— 1 min read

Denver-based biopharmaceutical company Cortech, Inc. and privately held diagnostics company BioStar, Inc. announced the termination of their agreement to merge, citing unfavorable test results and loss of collaborative partner support. This decision comes after negotiations to conclude the merger by May 31, 1998, fell through. Cortech, focused on developing therapeutics for inflammatory disorders, has reduced its staffing and discontinued internal research, while evaluating its strategic alternatives. BioStar develops point-of-care diagnostic tests using its proprietary thin-film technologies.

Key Takeaways:

  • Cortech and BioStar have terminated their merger agreement, effective immediately, due to disappointing test results and loss of collaborative partner support.
  • Cortech has substantially reduced its staffing and ceased internal research and development activities, focusing on evaluating its strategic alternatives.
  • BioStar develops point-of-care diagnostic tests using its proprietary thin-film technologies, including Optical ImmunoAssay (OIA) technology.
  • The company is developing additional thin-film technologies to broaden the range of applications and introduce new products.
  • Cortech's principal focus is on discovering and developing novel therapeutics for the treatment of inflammatory disorders.
  • Specific areas of research include protease inhibitors and bradykinin antagonists.

Statistics:

  • December 22, 1997: Date of initial announcement of the merger agreement between Cortech and BioStar.
  • May 31, 1998: Date by which the parties agreed to conclude the merger.
  • 1997: Year in which Cortech's Annual Report on Form 10-K highlighted risks and uncertainties associated with the company's business.

Sources:

  • Cortech, Inc. press release dated May 7, 1998
  • BioStar, Inc. (no external source provided, citing only the company name in the original text)
  • Securities and Exchange Commission filings by Cortech, Inc. (referenced as Cortech's Annual Report on Form 10-K for the year ended December 31, 1997)
  • PR Newswire, "Cortech and BioStar Announce Termination of Merger Agreement" dated May 7, 1998.

Read more